Theralase Technologies Inc. V.TLT

The thing is...

[floatinketucky]

This board is about the science of TLTFF. It's not about the people on the board. It's not about the company valuation compared to other overpriced items. 

Its about this incedable tech coming soon. 

Riight now Thealse is heads down dong important work. 

Consider this.....

$TLTFF-25 patients for potential Breakthrough Designation Approval-2021

Shawn Shirazi PhD, Chief Executive Officer, Theralase®, stated, "Another milestone has been reached by the Company with the addition of MU in Pennsylvania as a clinical study site. Theralase is focused on its target of enrolling and treating 11 additional patients in early 2021 for a total of 25 patients for potential Breakthrough Designation Approval and approximately 100 patients in 2021 / 2022."

https://www.accesswire.com/625524/Theralase-Launches-Third-Clinical-Study-Site-in-the-US-for-Phase-II-Bladder-Cancer-Clinical-Study
January 25, 2021

[floatinketucky]

On the comparison with Merck’s Keytruda, which has been approved for BCG-unresponsive NMIBC and has achieved a 19 per cent complete response at 12 months of treatment in the pivotal KEYNOTE-057 study, Uddin wrote, “For the 27 subjects in TLT’s pivotal trial to achieve the same CR rate at 360 days as Keytruda, an additional three subjects out of the 11 which had not received both doses of TLD-1433